Literature DB >> 16621595

Bacterial expression of functional, biotinylated peripheral cannabinoid receptor CB2.

Dmitriy Krepkiy1, Karen Wong, Klaus Gawrisch, Alexei Yeliseev.   

Abstract

A biotin-protein ligase recognition site (BRS) was inserted into a polypeptide comprised of the maltose-binding protein, the peripheral cannabinoid receptor (CB2), thioredoxin A, and a polyhistidine tag at the carboxy terminus. Expression levels of the recombinant receptor in Escherichia coli BL21(DE3) cells were approximately 1mg per liter of bacterial culture. The biotinylated CB2-fusion fully retained its ligand-binding capacity. Introduction of the BRS at the C-terminus of the CB2 fusion protein (construct CB2-109) resulted in its complete in vivo biotinylation; the biotinylated protein was streptavidin-binding competent. Positioning of the BRS near the N-terminus of CB2 (CB2-112) resulted in a very low level of biotinylation in vivo. However, the detergent solubilized and purified CB2-112 fusion protein were successfully biotinylated in vitro by action of a BirA biotin-protein ligase. The biotinylated CB2-112 fusion protein was cleaved by the tobacco etch virus protease at specifically inserted sites, and deposited onto monomeric avidin agarose beads. Biotinylation of the recombinant CB2 receptor enabled not only purification but also immobilization of the GPCR on a solid support in homogeneous orientation which is beneficial for subsequent structural characterization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621595     DOI: 10.1016/j.pep.2006.03.002

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  15 in total

1.  Real-time monitoring of NKCC2 endocytosis by total internal reflection fluorescence (TIRF) microscopy.

Authors:  Ankita Bachhawat Jaykumar; Paulo S Caceres; Ibrahim Sablaban; Bakhos A Tannous; Pablo A Ortiz
Journal:  Am J Physiol Renal Physiol       Date:  2015-11-04

2.  Use of dual affinity tags for expression and purification of functional peripheral cannabinoid receptor.

Authors:  Alexei Yeliseev; Lioudmila Zoubak; Klaus Gawrisch
Journal:  Protein Expr Purif       Date:  2006-12-12       Impact factor: 1.650

3.  Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum.

Authors:  Bhaswati Barat; Anna M Wu
Journal:  Biomol Eng       Date:  2007-02-15

4.  Expression and Preparation of a G-Protein-Coupled Cannabinoid Receptor CB2 for NMR Structural Studies.

Authors:  Alexei Yeliseev
Journal:  Curr Protoc Protein Sci       Date:  2019-01-09

5.  Application of Strep-Tactin XT for affinity purification of Twin-Strep-tagged CB2, a G protein-coupled cannabinoid receptor.

Authors:  Alexei Yeliseev; Lioudmila Zoubak; Thomas G M Schmidt
Journal:  Protein Expr Purif       Date:  2016-11-17       Impact factor: 1.650

6.  Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor.

Authors:  Maciej Wiktor; Sébastien Morin; Hans-Jürgen Sass; Fabian Kebbel; Stephan Grzesiek
Journal:  J Biomol NMR       Date:  2012-12-11       Impact factor: 2.835

7.  Application of HaloTag technology to expression and purification of cannabinoid receptor CB2.

Authors:  Silvia Locatelli-Hoops; Fangmin C Sheen; Lioudmila Zoubak; Klaus Gawrisch; Alexei A Yeliseev
Journal:  Protein Expr Purif       Date:  2013-03-05       Impact factor: 1.650

8.  Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)).

Authors:  Yuxun Zhang; Xiang-Qun Xie
Journal:  Protein Expr Purif       Date:  2008-03-07       Impact factor: 1.650

9.  A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.

Authors:  Jose Manuel Perez-Aguilar; Jin Xi; Felipe Matsunaga; Xu Cui; Bernard Selling; Jeffery G Saven; Renyu Liu
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

10.  High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1.

Authors:  Hui Ren; Daoyong Yu; Baosheng Ge; Brian Cook; Zhinan Xu; Shuguang Zhang
Journal:  PLoS One       Date:  2009-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.